News
STXS
2.270
-1.30%
-0.030
Weekly Report: what happened at STXS last week (0422-0426)?
Weekly Report · 6h ago
Weekly Report: what happened at STXS last week (0415-0419)?
Weekly Report · 04/22 12:11
Weekly Report: what happened at STXS last week (0408-0412)?
Weekly Report · 04/15 12:01
Weekly Report: what happened at STXS last week (0401-0405)?
Weekly Report · 04/08 12:08
BUZZ-U.S. STOCKS ON THE MOVE-VirTra, GE Vernova, Blackstone
U.S. Stock indexes fell on Tuesday. The Dow Jones Industrial Average was down 1.24% and the S&P 500 and Nasdaq Composite were also down. Investors grew concerned about the possibility of fewer interest rate cuts than expected from the Federal Reserve. GE Vernova was one of the top gainers on the NYSE.
Reuters · 04/02 16:27
Canopy Growth, Exact Sciences, Stereotaxis among healthcare movers
Healthcare On the Move: Canopy Growth, Exact Sciences, Stereotaxis among healthcare movers. S&P 500 Health Care Sector -1.52% to 1682.8. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/02 14:00
Weekly Report: what happened at STXS last week (0325-0329)?
Weekly Report · 04/01 12:04
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
TipRanks · 03/25 12:45
Weekly Report: what happened at STXS last week (0318-0322)?
Weekly Report · 03/25 12:08
Weekly Report: what happened at STXS last week (0311-0315)?
Weekly Report · 03/18 12:06
Stereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust Financials
TipRanks · 03/18 10:35
Weekly Report: what happened at STXS last week (0304-0308)?
Weekly Report · 03/11 12:01
Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months
Stereotaxis is on the brink of numerous regulatory submissions and approvals in the next 10 months. The Magic catheter human trial was successful in Lithuania. The company reported $4.56 million in sales in Q4 and expects to submit the catheter to EU and US regulators in May or June. The semi-mobile robot is expected to be approved in Europe in mid-2024 and the US in Q3.
Seeking Alpha · 03/09 05:58
Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter
NASDAQ · 03/08 12:50
Stereotaxis Price Target Raised to $4.00/Share From $3.00 by Lake Street
Dow Jones · 03/05 17:22
Stereotaxis Is Maintained at Buy by Lake Street
Dow Jones · 03/05 17:22
Lake Street Maintains Buy on Stereotaxis, Raises Price Target to $4
Benzinga · 03/05 17:11
Roth MKM Reiterates Buy on Stereotaxis, Maintains $5 Price Target
Benzinga · 03/05 15:23
Stereotaxis Ord: Current report
Press release · 03/05 00:47
12 Health Care Stocks Moving In Monday's After-Market Session
Vicarious Surgical shares moved upwards by 24.9% to $0.45 during Monday's after-market session. The company's, Q4 earnings came out today. Ekso Bionics Holdings (NASDAQ:EKSO) stock increased by 21.42% in the same session.
Benzinga · 03/04 21:32
More
Webull provides a variety of real-time STXS stock news. You can receive the latest news about Stereotaxis Ord through multiple platforms. This information may help you make smarter investment decisions.
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.